SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as investors debate whether the low-market-cap meme coin is a legitimate scaling opportunity or a high-risk pump-and-dump scheme. The community is actively tracking whale wallet movements and liquidity patterns, with participants weighing the potential for massive gains against warnings of a total rug pull.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is capturing significant retail interest driven by its concentrated exposure to private tech leaders like SpaceX and Anthropic, which investors are tracking closely ahead of potential IPO activity. The community is actively debating the stock's substantial premium to its net asset value, with traders comparing its valuation mechanics to other proxy investment funds in the sector.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is trending as retail traders scramble for exposure to AI leaders like OpenAI, Anthropic, and SpaceX, fueling a meme-like frenzy that has sent the stock soaring despite warnings of extreme overvaluation relative to its net asset value. Community members are actively debating the sustainability of this parabolic run, with many highlighting that the limited tradable float due to lockup periods is creating intense volatility and aggressive short-squeeze dynamics.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle ($CRCL) is experiencing significant volatility following a leaked draft of the Clarity Act, which proposes banning stablecoin yield-sharing models and has sparked intense debate over the long-term viability of the company's revenue model. While some retail investors are buying the dip and betting on Circles role as a future payment utility, others remain skeptical, pointing to aggressive insider selling and ongoing regulatory uncertainty as signs of an overvalued asset.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is trending as traders debate its long-term viability amid ongoing supply reduction rumors and institutional classification as a digital commodity. While the community remains divided between long-term holders expressing bullish conviction and skeptics labeling the asset a high-risk gamble, activity is surging as investors closely monitor whale accumulation patterns and potential market shifts.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is seeing heightened market attention as traders debate the sustainability of its recent pullback, with community sentiment split between viewing current price levels as a generational buying opportunity and fearing further downside from macro-economic pressures and AI-driven competition. Investors are closely monitoring key technical support levels, active institutional rebalancing, and ongoing developments in AI-integrated search and cloud infrastructure as the primary catalysts driving recent volatility.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors debate whether the company's AI-driven platform and mortgage innovation represent a high-growth turnaround or a business model inherently vulnerable to high mortgage rates and macroeconomic pressures. The community remains intensely polarized, with bulls highlighting the firms increasing acquisition volume and leadership strategy, while bears continue to focus on the company's profitability challenges and its sensitivity to broader market volatility.

MMTec, Inc. engages in the holding of an equity interest in MM Future. It operates through the Gujia, MM Future and HC Securities and MM Global. The Gujia, MM Future and HC Securities segment provide market data services and consulting services. The MM Global segment is involved in introducing a broker that clears all transactions through a clearing broker dealer and earns commission income, placement agent services fee, and other related income from customers. The company was founded on January 4, 2018 and is headquartered in Hong Kong.

Mmtec Inc

Mmtec Inc is generating intense retail attention as investors weigh the company's appeal against a Nasdaq delisting notice, drawing frequent comparisons to high-volatility Chinese stock plays. The community is actively debating the stock's massive swings, with bulls aggressively targeting potential short squeezes while bears warn of the company's underlying financials and potential delisting risks.

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. The company was founded by Randall L. Halcomb, Martijn Fenaux, and Weidong Zhong in 2017 and is headquartered in Foster City, CA.

Terns Pharmaceuticals Inc

Terns Pharmaceuticals is capturing significant investor attention following promising Phase 1 clinical data for its leukemia candidate, TERN-701, which has sparked intense debate over the company's valuation and potential as an acquisition target. The community is deeply divided between bulls citing the drug's best-in-disease profile and analysts raising price targets, while bears express skepticism about the sustainability of the current valuation and the potential for near-term dilutive share offerings.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is trending as investors focus on recent positive updates regarding Medicare coverage prospects and the company's strong clinical test volume growth, which is being driven by its pivotal role in the precision oncology ecosystem alongside Tempus. The community is actively debating the company's long-term potential as a 'picks and shovels' leader in cancer diagnostics, closely monitoring upcoming earnings and the timing of regulatory milestones that could trigger a significant re-rating of the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aceragen, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of medications for rare and orphan diseases. The firm's product portfolio includes ACG-801 and ACG-701, which targets Farber Disease, Melioidosis, and Cystic Fibrosis. The company was founded in 1989 and is headquartered in Exton, PA.

IDRA
Idera Pharmaceuticals, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest IDRA News

IDRAIdera Pharmaceuticals, Inc.